Despite the development of many new anti-seizure drugs over the past two decades, around one-third of individuals with epilepsy are without effective treatment. This pharmacoresistance is poorly understood, but new treatments targeting epileptogenesis instead of seizures have shown potential in animal models and are now being translated into the clinic.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Non-adherence and epileptic emergency—reasons and solutions
Clinical Epileptology Open Access 14 September 2023
-
Syntabulin regulates neuronal excitation/inhibition balance and epileptic seizures by transporting syntaxin 1B
Cell Death Discovery Open Access 22 June 2023
-
Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling
Nature Neuroscience Open Access 23 June 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Devinsky, O. et al. Epilepsy. Nat. Rev. Dis. Primers 4, 18024 (2018).
Löscher, W., Potschka, H., Sisodiya, S. M. & Vezzani, A. drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol. Rev. 72, 606–638 (2020).
Chen, Z., Brodie, M. J., Liew, D. & Kwan, P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs. JAMA Neurol. 75, 279 (2018).
Lerche, H. et al. Ion channels in genetic and acquired forms of epilepsy. J. Physiol. 591, 753–764 (2013).
Doeser, A. et al. Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug. Brain 138, 371–387 (2015).
Tang, M., Park, S. H., De Vivo, D. C. & Monani, U. R. Therapeutic strategies for glucose transporter 1 deficiency syndrome. Ann. Clin. Transl Neurol. 6, 1923–1932 (2019).
Wolff, M. et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain 140, 1316–1336 (2017).
French, J. A. et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST‑3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388, 2153–2163 (2016).
Wykes, R. C. et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci. Transl Med. 4, 161ra152 (2012).
Han, Z. et al. Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. Sci. Transl Med. 12, eaaz6100 (2020).
Acknowledgements
The work of H.L. is supported by the German Research Foundation (DFG, Research Unit FOR-2715, grants Le 1030/14-1, /15-1 and /16-1) and by the Federal Ministry for Education and Research (BMBF, Treat-ION, 01GM1907A).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.L. has received personal honoraria for consulting or speaking from Arvelle, Bial, Biomarin, Desitin, Eisai and UCB; travel support from Bial, Desitin, Eisai and UCB; and research support from Bial, none directly related to any of the work presented here. He is a clinical investigator of the eslicarbazepine acetate trial (EudraCT Number: 2018-002747-29).
Rights and permissions
About this article
Cite this article
Lerche, H. Drug-resistant epilepsy — time to target mechanisms. Nat Rev Neurol 16, 595–596 (2020). https://doi.org/10.1038/s41582-020-00419-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-020-00419-y
This article is cited by
-
Syntabulin regulates neuronal excitation/inhibition balance and epileptic seizures by transporting syntaxin 1B
Cell Death Discovery (2023)
-
Non-adherence and epileptic emergency—reasons and solutions
Clinical Epileptology (2023)
-
Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling
Nature Neuroscience (2022)
-
Current Principles in the Management of Drug-Resistant Epilepsy
CNS Drugs (2022)
-
Neurology at the crossroads
Nature Reviews Neurology (2020)